Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.

Carr L., Norris K., Parker H., Nilsson-Takeuchi A., Bryant D., Amarasinghe H., Kadalayil L., Else M., Pettitt A., Hillmen P., Schuh A., Walewska R., Baird DM., Oscier DG., Oakes CC., Gibson J., Pepper C., Strefford JC.

DOI

10.1111/bjh.19765

Type

Journal article

Journal

Br J Haematol

Publication Date

10/09/2024

Permalink Original publication